• Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use
Friday, July 11, 2025
32 °c
Agartala
enewstime
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    Hockey India names 33-man core group for senior men's national camp

    Hockey India names 33-man core group for senior men's national camp

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Red Bull sack F1 team principal Christian Horner

    Red Bull sack F1 team principal Christian Horner

    Stuart Broad labels Australia’s current top three 'the most muddled'

    Stuart Broad labels Australia’s current top three 'the most muddled'

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    Hockey India names 33-man core group for senior men's national camp

    Hockey India names 33-man core group for senior men's national camp

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Red Bull sack F1 team principal Christian Horner

    Red Bull sack F1 team principal Christian Horner

    Stuart Broad labels Australia’s current top three 'the most muddled'

    Stuart Broad labels Australia’s current top three 'the most muddled'

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
enewstime
  • Home
  • News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders
Home Health

Experimental drug shows potential in preventing or slowing Diabetic eye disease, Study finds

ENEWSTIME Desk by ENEWSTIME Desk
May 26, 2023
in Health
30
VIEWS
Share on FacebookShare on Twitter

A recent study conducted by researchers, including an Indian-origin scientist, has provided promising evidence that an experimental drug could potentially aid in preventing or slowing down vision loss among individuals with diabetes.

The findings, which have been published in the Journal of Clinical Investigation, stem from a comprehensive investigation utilizing mouse models, human retinal organoids, and eye cell lines.

The research was primarily conducted by the team at the Wilmer Eye Institute, Johns Hopkins Medicine, with a specific focus on two prevalent diabetic eye conditions: proliferative diabetic retinopathy and diabetic macular edema.

Both of these conditions directly impact the retina, which serves as the light-sensing tissue located at the back of the eye and is responsible for transmitting visual signals to the brain.

In proliferative diabetic retinopathy, abnormal blood vessels excessively grow on the surface of the retina, leading to bleeding, retinal detachments, and severe vision impairment.

Diabetic macular edema, on the other hand, involves the leakage of fluid from blood vessels in the eye, causing swelling in the central retina and damaging the retinal cells responsible for central vision.

The study revealed that a specific compound known as 32-134D displayed potential in preventing diabetic retinal vascular diseases by reducing the levels of a protein called HIF, or hypoxia-inducible factor.

“Our findings demonstrated that 32-134D was remarkably well-tolerated when applied to the eyes and effectively reduced HIF levels in diseased eyes,” stated Dr. Akrit Sodhi, Associate Professor of Ophthalmology at Johns Hopkins and the Wilmer Eye Institute.

To evaluate the efficacy of 32-134D, the researchers administered the compound to various types of human retinal cell lines associated with the expression of proteins that promote blood vessel production and leakage.

Upon analyzing the genes regulated by HIF in cells treated with 32-134D, the researchers observed a return to near-normal levels of gene expression.

This outcome proved sufficient in halting the formation of new blood vessels and maintaining the structural integrity of existing vessels.

Furthermore, the researchers tested 32-134D in two distinct mouse models of diabetic eye disease by administering injections directly into the eye. After five days, they observed reduced levels of HIF and noted that the drug effectively hindered the formation of new blood vessels and prevented vessel leakage.

Consequently, this slowed down the progression of the eye disease in the animal models.

Dr. Sodhi and his team were pleasantly surprised to discover that 32-134D remained active in the retina for approximately 12 days following a single injection, without causing harm to retinal cells or tissue degradation.

“This research highlights the potential of inhibiting HIF with 32-134D as not only an effective therapeutic approach but also a safe one,” emphasized Dr. Sodhi, while emphasizing the need for further animal model studies before advancing to clinical trials. (Edited)

Related Posts

Spine a medical miracle and corporate necessity for self-belief: Gautam Adani
Health

Spine a medical miracle and corporate necessity for self-belief: Gautam Adani

July 11, 2025
World Population Day: Planned parenthood key for better maternal, child health, says Nadda
Health

World Population Day: Planned parenthood key for better maternal, child health, says Nadda

July 11, 2025
Microsoft’s new AI system to help decode protein motion, advance drug discovery: Satya Nadella
Health

Microsoft’s new AI system to help decode protein motion, advance drug discovery: Satya Nadella

July 11, 2025
From farms to factories: How Tamil Nadu’s incubation hubs are boosting rural livelihoods
Health

From farms to factories: How Tamil Nadu’s incubation hubs are boosting rural livelihoods

July 11, 2025
Disability services must include health screening, stress management for caregivers: Study
Health

Disability services must include health screening, stress management for caregivers: Study

July 10, 2025
Former Telangana CM KCR again admitted to hospital
Health

Former Telangana CM KCR again admitted to hospital

July 10, 2025
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

Spine a medical miracle and corporate necessity for self-belief: Gautam Adani

Awami League Slams ICT Alleging Coercion of Ex-IGP to Testify Against Hasina

Bloodshed in West Bengal’s Bhangar returns

World Population Day: Planned parenthood key for better maternal, child health, says Nadda

Anupam Kher on President watching ‘Tanvi The Great’: She’s the epitome of different but no less

Income Tax Dept releases excel utilities for ITR-2 and ITR-3 forms

Contact us

19, Old Thana Road. Banamalipur. PO. Agartala. Pin code 799001. Tripura (West), India.

Email: enewstime2017@gmail.com

Wa: 8794548041

  • Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders

© 2025 Designed & Developed with ❤️ by Provibe Media LLP